Cancer
Showing NaN - NaN of 78
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
Genetic Predisposition, Cancer Trial in San Antonio (DNA or RNA Sequencing)
Not yet recruiting
- Genetic Predisposition
- Cancer
- DNA or RNA Sequencing
-
San Antonio, TexasUniversity of Texas Health Science Center
Jan 23, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Cancer, Sleep Disturbance, Anxiety Trial in San Francisco (Calm Meditation, Health Education Podcast)
Not yet recruiting
- Cancer
- +5 more
- Calm Meditation
- Health Education Podcast
-
Phoenix, Arizona
- +1 more
Jan 11, 2023
NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
- Darbepoetin alfa
- Placebo
-
Anniston, Alabama
- +566 more
Nov 4, 2022
Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))
Recruiting
- Acute Myeloid Leukemia (AML)
- Cancer
- Venetoclax
- +2 more
-
Scottsdale, Arizona
- +169 more
Aug 23, 2022
S1204, Viral Screening in Newly Diagnosed Cancer Patients
Active, not recruiting
- Cancer
-
Fontana, California
- +57 more
Aug 22, 2022
Acute Myeloid Leukemia (AML), Cancer Trial in United States (venetoclax, azacytidine, decitabine)
Completed
- Acute Myeloid Leukemia (AML)
- Cancer
- venetoclax
- +2 more
-
Tempe, Arizona
- +15 more
Jun 10, 2022
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
Host Immune Response to Novel RNA COVID-19 Vaccination
Recruiting
- COVID-19 Vaccine
- Cancer
- COVID-19 Vaccine
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Apr 22, 2022
Cancer Trial in Canada, United States (Vopratelimab, Ipilimumab)
Active, not recruiting
- Cancer
-
Beverly Hills, California
- +20 more
Apr 4, 2022
Aspirin in Reducing Events in the Elderly
Active, not recruiting
- Functional Disability
- +6 more
- 100 mg enteric-coated aspirin
- Placebo
-
Birmingham, Alabama
- +46 more
Apr 2, 2021